Talphera price target lowered to $3.50 from $4.25 at Alliance Global Partners

Alliance Global Partners lowered the firm’s price target on Talphera to $3.50 from $4.25 and keeps a Buy rating on the shares post the Q2 report. The firm cites the hold on the company’s PFS assets and the delays in the NEPHRO study for the target cut.